Sanmay Sarada is Co-Founder and CTO at Astraea, a Y Combinator-backed agentic platform automating clinical trial data analysis and statistical programming for FDA-ready submissions. He studied Computer Science at Stanford University, bringing deep technical expertise to the intersection of healthcare data and AI.

Prior to Astraea, Sanmay built clinical and hospital data infrastructure across diagnostic software systems, gaining firsthand experience with the complexity of regulated healthcare environments and data pipelines.

Sanmay identified a critical industry gap: clinical trial biometrics workflows had not meaningfully improved in decades, leaving pharma teams spending months on manual data transformation that AI could now execute in days.

At Astraea, Sanmay leads the technical architecture of an end-to-end biometrics platform that automates SDTM, ADaM, TFL generation, and Pinnacle 21 checks, all within a HIPAA, GDPR, and 21 CFR Part 11 compliant system.

Astraea is already trusted by 10 or more global pharma and biotech sponsors, compressing biometrics-to-reporting windows by 30 to 50 percent and turning months of manual programming into days of automated, auditable execution.